CJ BIOSCIENCE

Serial Number 97122539
Registration 7394693
700

Registration Progress

Application Filed
Nov 12, 2021
Under Examination
Approved for Publication
Feb 21, 2024
Published for Opposition
Mar 12, 2024
Registered
May 28, 2024

Trademark Image

CJ BIOSCIENCE

Basic Information

Serial Number
97122539
Registration Number
7394693
Filing Date
November 12, 2021
Registration Date
May 28, 2024
Published for Opposition
March 12, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
May 28, 2024
Registration
Registered
Classes
005 029

Rights Holder

CJ Corporation

03
Address
12, Sowol-ro 2-gil, Jung-gu
Seoul 04637
KR

Ownership History

CJ Corporation

Original Applicant
03
Seoul KR

CJ Corporation

Owner at Publication
03
Seoul KR

CJ Corporation

Original Registrant
03
Seoul KR

Legal Representation

Attorney
Boris Umansky

USPTO Deadlines

Next Deadline
1596 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240528)
Due Date
May 28, 2030
Grace Period Ends
November 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
May 28, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 28, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 24, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 22, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Sep 27, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 27, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Sep 27, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Sep 26, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 26, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 26, 2023 ALIE A ASSIGNED TO LIE Loading...
May 8, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 6, 2023 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 6, 2023 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Feb 6, 2023 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Aug 3, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 3, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 3, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 12, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 19, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 19, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 19, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 12, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 19, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 18, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 16, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
food for babies; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vitamin preparations; reagents for use in veterinary genetic testing; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biological preparations for the treatment of cancer; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; dietetic foods adapted for medical purposes; reagents for use in medical genetic testing; genetic identity tests comprised of reagents for medical purposes; diagnostic reagents for medicinal use; diagnostic preparations for medical purposes; probiotic bacterial formulations for medical use; probiotic preparations for medical use; pharmaceutical preparations, namely, antivirals; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating sunburn; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for skin care; pharmaceutical preparations, namely, appetite suppressant; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceuticals, namely, anti-infectives; pharmaceutical preparations for wounds; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating allergies; medicines for adjusting the menstrual cycle; medicines for intestinal disorders; medicines for the treatment of gastrointestinal diseases; probiotic supplements; pharmaceutical preparations for animal skincare; mineral food supplements; nutraceuticals for use as a dietary supplement; nutraceutical preparations mainly based on lactic acid bacteria for use as a dietary supplement; nutraceutical preparations mainly based on probiotics for use as a dietary supplement; cultures of microorganisms for medical or veterinary use; bacterial preparations for medical and veterinary use; health supplements food mainly based on processed fruits; health supplements food mainly based on processed vegetable; health supplements food mainly based on processed meats; health supplements food mainly based on bifidus bacteria; health supplements food mainly based on lactic acid bacteria; health supplements food mainly based on probiotics extracted from dairy products; health supplements food mainly based on probiotics of lactic acid bacteria; health supplements food mainly based on processed seeds; health supplements food mainly based on processed fish and shellfish; health supplements food mainly based on probiotics of lactic acid bacteria extracted from dairy products
Class 029
preserved, frozen, dried and cooked fruits and vegetables; processed vegetables and fruits; preserved, dried and cooked fruit and vegetables; powdered milk; dairy-based beverages; cream, being dairy products; dairy-based spreads; lactic acid bacteria drinks; milk products excluding ice cream, ice milk and frozen yogurt

Additional Information

Design Mark
The mark consists of three colors, namely, blue, orange and red, that are in egg-like shapes, located to the right of the letters "CJ" in black and to the left of the wording "BIOSCIENCE", also in black. The upper left egg-like shape is blue, the middle right egg-like shape is orange, and the lower left egg-like shape is red.
Color Claim
The color(s) black, blue, orange and red is/are claimed as a feature of the mark.

Classification

International Classes
005 029

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"